Latest On ANI Pharmaceuticals, Inc (ANIP):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-31 02:07 EST | News | ANI Pharmaceuticals: Strong Revenue Growth And ANDA Approvals | N/A |  |
| 2023-05-15 20:53 EST | News | ANI Pharma gains as FDA clears generics for Celontin and Fosamax | N/A | |
| 2023-05-12 20:30 EST | News | ANI Pharmaceuticals down 6%, prices $75M offering | N/A | |
| 2023-05-12 06:14 EST | News | ANI Pharmaceuticals announces proposed stock offering, shares fall 6% after hours | N/A | |
| 2023-05-08 20:59 EST | News | ANI Pharmaceuticals soars ~10% after Q1 beat, raises outlook amid rare disease focus | N/A | |
| 2023-05-08 20:59 EST | News | ANI Pharmaceuticals, Inc. (ANIP) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-08 07:43 EST | News | ANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31M | N/A | |
| 2023-05-05 23:59 EST | News | ANI Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-04-24 15:29 EST | News | ANI Pharmaceuticals stock rises after FDA approval of generic antibiotic | N/A | |
| 2023-04-04 10:27 EST | News | ANI Pharma's generic cholesterol-lowering drug gets FDA approval | N/A | |
| 2023-03-10 04:47 EST | News | ANI Pharmaceuticals, Inc. (ANIP) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-09 13:04 EST | News | ANI Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.09, revenue of $94.2M beats by $8.06M | N/A | |
| 2023-03-08 22:19 EST | News | ANI Pharmaceuticals Q4 2022 Earnings Preview | N/A | |
| 2023-03-01 22:47 EST | News | ANI Pharma draws Buy at Guggenheim on potential of autoimmune therapy | N/A | |
| 2023-01-01 20:02 EST | News | 2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To Benefit | N/A | |
| 2022-12-20 07:38 EST | News | ANI Pharmaceuticals gets FDA approval for generic levocarnitine tablets | N/A | |
| 2022-11-16 07:53 EST | News | ANI Pharmaceuticals launches generic antibiotic trimethoprim with FDA approval in bag | N/A | |
| 2022-11-09 20:16 EST | News | ANI Pharmaceuticals reports Q3 earnings beat; reaffirms FY22 guidance | N/A | |
| 2022-11-09 20:14 EST | News | ANI Pharmaceuticals, Inc. (ANIP) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-09 02:13 EST | News | ANI Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-09-14 00:52 EST | News | ANI Pharmaceuticals (ANIP) presents at H.C. Wainwright 24th Annual Global Investment Conference - Slideshow | N/A | |
| 2022-08-30 01:03 EST | News | ANI Pharma launches generic Prochlorperazine maleate tablets | N/A | |
| 2022-08-16 21:11 EST | News | ANI Pharmaceuticals' generic dexamethasone tablets get FDA approval | N/A | |
| 2022-08-08 18:58 EST | News | ANI Pharmaceuticals Q2 mixed earnings; raises FY 2022 revenue guidance for Cortrophin | N/A | |
| 2022-08-08 18:57 EST | News | ANI Pharma stock rises on Q2 revenue beat, in-line 2022 forecast | N/A | |
| 2022-08-08 18:57 EST | News | ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-05 14:37 EST | News | ANI Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-06-22 15:19 EST | News | ANI Pharmaceuticals' generic drug for anxiety disorder gets FDA approval | N/A | |
| 2022-06-22 15:18 EST | News | Hot Stocks: WGO rises on earnings, ANIP gains on FDA approval, AVT pops on new partnership, while ORA falls | N/A | |
| 2022-06-02 21:40 EST | News | ANI Pharmaceuticals to cease operations at Oakville, Canada manufacturing plant | N/A | |
| 2022-06-02 03:17 EST | News | ANI Pharma rises after hours on FDA approval for fludrocortisone acetate tablets | N/A | |
| 2022-05-10 23:50 EST | News | ANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55M | N/A | |
| 2022-05-10 23:49 EST | News | ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 01:59 EST | News | ANI Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-03-15 16:49 EST | News | ANI Pharmaceuticals Non-GAAP EPS of $0.54 misses by $0.20, revenue of $60.9M beats by $4.6M | N/A | |
| 2022-03-15 16:48 EST | News | ANI Pharma reaches a seven-month low on soft guidance for 2022 | N/A | |
| 2022-03-15 16:47 EST | News | ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-14 23:38 EST | News | ANI Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2022-02-09 07:25 EST | News | ANI Pharmaceuticals: Back In The Buy Zone | N/A | |
| 2022-01-12 18:27 EST | News | FTC final order settling antitrust charges clears way for ANI acquisition of Novitium | N/A | |
| 2021-12-21 16:27 EST | News | ANI Pharmaceuticals announces FDA approval of Mycobutin generic | N/A | |
| 2021-11-11 21:20 EST | News | ANI Pharma acquisition of Novitium cleared by FTC | N/A | |
| 2021-11-11 01:06 EST | News | ANI Pharma, Novitium to divest two generic products as part of merger | N/A | |
| 2021-11-04 03:50 EST | News | ANI Pharmaceuticals launches stock offering | N/A | |
| 2021-11-01 15:13 EST | News | FDA grants expanded approval for ANI Pharmaceuticals' Cortrophin Gel | N/A | |
| 2021-11-01 15:13 EST | News | ANI Pharmaceuticals EPS beats by $0.31, beats on revenue | N/A | |
| 2021-11-01 15:11 EST | News | ANI Pharma surges 44% following strong earnings, expanded approval; hits 52-week high | N/A | |
| 2021-11-01 15:10 EST | News | ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-31 19:33 EST | News | ANI Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-10-02 06:16 EST | News | ANI Pharmaceuticals (ANIP) Investor Presentation - Slideshow | N/A | |
About ANI Pharmaceuticals, Inc (ANIP):
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.
General
- Name ANI Pharmaceuticals, Inc
- Symbol ANIP
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 369
- Last Split Factor1:6
- Last Split Date2013-07-18
- Fiscal Year EndDecember
- IPO Date2000-05-05
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.anipharmaceuticals.com
View More
Valuation
- Trailing PE 77.58
- Forward PE 8.31
- Price/Sales (Trailing 12 Mt.) 1.75
- Price/Book (Most Recent Quarter) 1.84
- Enterprise Value Revenue 2.59
- Enterprise Value EBITDA 19.21
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $3.44
- Next Year EPS Estimate $4.43
- Next Quarter EPS Estimate $0.87
- Profit Margin -11%
- Operating Margin -2%
- Return on Assets -1%
- Return on Equity -11%
- Revenue 208.48 million
- Earnings Per Share $1.34
- Revenue Per Share $17.43
- Gross Profit 125.62 million
- Quarterly Earnings Growth 19.4%
View More
Highlights
- Market Capitalization 408.05 million
- EBITDA 39.87 million
- PE Ratio 55.14
- PEG Ratio 1.06
- Analyst Target Price $38.33
- Book Value Per Share $16.31
View More
Share Statistics
- Shares Outstanding 12.35 million
- Shares Float 9.25 million
- % Held by Insiders 474%
- % Held by Institutions 79.46%
- Shares Short 542783
- Shares Short Prior Month 521318
- Short Ratio 10.51
- Short % of Float 7%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta 1.23
- 52 Week High $52.22
- 52 Week Low $23.55
- 50 Day Moving Average 30.62
- 200 Day Moving Average 29.54
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
ANI Pharmaceuticals, Inc (ANIP) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
ANI Pharmaceuticals, Inc (ANIP) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-09 | $57.25 million | $0.80 | $0.94 | -15.19% |
| 2020-09-30 | 2020-11-05 | $52.98 million | $0.97 | $0.88 | 9.82% |
| 2020-06-30 | 2020-08-06 | $N/A | $0.69 | $0.75 | -7.59% |
| 2020-03-31 | 2020-05-07 | $N/A | $1.04 | $0.89 | 16.85% |
| 2019-12-31 | 2020-02-27 | $47.97 million | $1.08 | $1.18 | -8.73% |
| 2019-09-30 | 2019-11-06 | $51.34 million | $1.23 | $1.43 | -13.99% |
| 2019-06-30 | 2019-08-07 | $54.36 million | $1.44 | $1.29 | 12.06% |
| 2019-03-31 | 2019-05-09 | $52.89 million | $1.30 | $1.05 | 24.2% |
| 2018-12-31 | 2019-02-27 | $57.12 million | $1.32 | $1.24 | 6.45% |
| 2018-09-30 | 2018-11-06 | $50.7 million | $1.29 | $1.17 | 10.26% |
| 2018-06-30 | 2018-08-07 | $47.27 million | $1.13 | $1.34 | -15.67% |
| 2018-03-31 | 2018-05-08 | $46.48 million | $1.32 | $1.28 | 3.53% |
| 2017-12-31 | 2018-02-27 | $47.29 million | $1.08 | $1.05 | 3.35% |
| 2017-09-30 | 2017-11-02 | $48.16 million | $1.11 | $0.99 | 12.12% |
| 2017-06-30 | 2017-08-03 | $44.76 million | $0.98 | $0.86 | 13.95% |
| 2017-03-31 | 2017-05-04 | $36.63 million | $0.74 | $0.79 | -6.33% |
| 2016-12-31 | 2017-03-02 | $38.21 million | $0.90 | $1.10 | -18.18% |
| 2016-09-30 | 2016-11-03 | $38.53 million | $1.09 | $1.08 | 1.24% |
| 2016-06-30 | 2016-08-04 | $31.34 million | $1.11 | $0.77 | 44.16% |
| 2016-03-31 | 2016-05-05 | $20.56 million | $0.76 | $0.70 | 8.57% |
| 2015-12-31 | 2016-02-23 | $18.04 million | $0.52 | $0.58 | -9.57% |
| 2015-09-30 | 2015-11-03 | $19.97 million | $0.80 | $0.56 | 42.86% |
| 2015-06-30 | 2015-08-04 | $19.52 million | $0.55 | $0.54 | 1.85% |
| 2015-03-31 | 2015-05-05 | $18.8 million | $0.57 | $0.56 | 1.79% |
| 2014-12-31 | 2015-02-19 | $21.04 million | $0.42 | $0.59 | -28.81% |
| 2014-09-30 | 2014-11-03 | $17.39 million | $0.66 | $0.46 | 43.48% |
| 2014-06-30 | 2014-08-04 | $6.65 million | -$0.21 | -$0.01 | -2000% |
| 2014-03-31 | 2014-05-05 | $10.9 million | $0.33 | $0.32 | 3.13% |
| 2013-12-31 | 2014-02-18 | $15.95 million | $0.41 | $0.24 | 70.83% |
| 2013-09-30 | 2013-11-07 | $7.84 million | $0.13 | ||
| 2013-06-30 | 2013-08-09 | $6.15 million | -$6.02 | ||
| 2013-03-31 | 2013-05-13 | $145040 | -$0.56 | ||
| 2012-12-31 | 2013-03-01 | $1.97 million | -$1.10 | ||
| 2012-09-30 | 2012-11-08 | $110383 | -$1.62 | -$1.80 | 10% |
| 2012-06-30 | 2012-08-01 | $108780 | -$2.16 | -$2.46 | 12.2% |
| 2012-03-31 | 2012-05-08 | $114000 | -$3.24 | -$1.98 | -63.64% |
| 2011-12-31 | 2012-03-13 | -$2.16 | -$4.05 | 46.67% | |
| 2011-09-30 | 2011-11-09 | $182784 | -$4.32 | -$5.10 | 15.29% |
| 2011-06-30 | 2011-07-25 | $81003 | -$5.76 | -$6.48 | 11.11% |
| 2011-03-31 | 2011-05-10 | -$7.20 | -$5.18 | -39% | |
| 2010-12-31 | 2011-03-16 | -$6.48 | -$5.31 | -22.03% | |
| 2010-09-30 | 2010-11-12 | -$5.76 | -$5.04 | -14.29% | |
| 2010-06-30 | 2010-08-12 | -$6.12 | -$3.78 | -61.9% | |
| 2010-03-31 | 2010-05-14 | -$6.84 | -$3.78 | -80.95% | |
| 2009-12-31 | 2010-03-30 | -$31.32 | -$3.96 | -690.91% | |
| 2009-09-30 | 2009-11-09 | -$7.56 | -$5.76 | -31.25% | |
| 2009-06-30 | 2009-08-07 | -$6.12 | -$5.40 | -13.33% | |
| 2009-03-31 | 2009-05-11 | -$5.40 | -$5.76 | 6.25% | |
| 2008-12-31 | 2009-03-16 | -$1.80 | -$8.64 | 79.17% | |
| 2008-09-30 | 2008-11-10 | -$8.64 | -$7.20 | -20% | |
| 2008-06-30 | 2008-08-11 | -$7.92 | -$5.76 | -37.5% | |
| 2008-03-31 | 2008-05-09 | -$4.68 | -$3.60 | -30% | |
| 2007-12-31 | 2008-03-17 | -$2.16 | -$2.88 | 25% | |
| 2007-09-30 | 2007-11-13 | -$2.16 | -$3.69 | 41.46% | |
| 2007-06-30 | 2007-08-14 | -$3.60 | -$3.24 | -11.11% | |
| 2007-03-31 | 2007-05-01 | -$2.88 | -$2.88 | 0% | |
| 2006-12-31 | 2007-03-08 | $15.84 | -$2.88 | 650% | |
| 2006-09-30 | 2006-11-14 | -$1.08 | -$4.14 | 73.91% | |
| 2006-06-30 | 2006-08-14 | -$3.96 | -$5.22 | 24.14% | |
| 2006-03-31 | 2006-05-12 | -$6.12 | -$6.48 | 5.56% | |
| 2005-12-31 | 2006-03-31 | -$4.68 | -$4.41 | -6.12% | |
| 2005-09-30 | 2005-11-10 | -$3.60 | -$4.86 | 25.93% | |
| 2005-06-30 | 2005-08-12 | -$4.68 | -$5.40 | 13.33% | |
| 2005-03-31 | 2005-05-13 | -$5.04 | -$5.22 | 3.45% | |
| 2004-12-31 | 2005-02-15 | -$7.92 | -$6.30 | -25.71% | |
| 2004-09-30 | 2004-11-12 | -$5.76 | -$5.76 | 0% | |
| 2004-06-30 | 2004-08-16 | -$5.55 | |||
| 2004-03-31 | 2004-05-17 | -$6.12 | -$4.32 | -41.67% | |
| 2003-12-31 | 2004-03-09 | -$3.96 | |||
| 2003-09-30 | 2003-11-12 | -$4.31 | |||
| 2003-06-30 | 2003-08-16 | -$6.41 | |||
| 2003-03-31 | 2003-05-15 | -$4.96 | |||
| 2002-12-31 | 2002-12-31 | -$1.97 | |||
| 2002-09-30 | 2002-09-30 | -$3.91 | |||
| 2002-06-30 | 2002-06-30 | -$7.93 | |||
| 2002-03-31 | 2002-03-31 | -$5.85 | |||
| 2001-12-31 | 2001-12-31 | -$7.84 | |||
| 2001-09-30 | 2001-09-30 | $1.87 |
ANI Pharmaceuticals, Inc (ANIP) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
ANI Pharmaceuticals, Inc (ANIP) Chart:
ANI Pharmaceuticals, Inc (ANIP) News:
Below you will find a list of latest news for ANI Pharmaceuticals, Inc (ANIP) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
ANI Pharmaceuticals, Inc (ANIP) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 30 | 0 | CALL | 0 | 0 | 57.43 | TRUE | 0 | 0 |
| 2025-01-17 | 35 | 0 | CALL | 0 | 0 | 107.32 | TRUE | 0 | 0 |
| 2025-01-17 | 40 | 0 | CALL | 0 | 0 | 51.3 | TRUE | 0 | 0 |
| 2025-01-17 | 45 | 0 | CALL | 0 | 0 | 42.97 | TRUE | 0 | 0 |
| 2025-01-17 | 50 | 13.5 | CALL | 0 | 100 | 37.03 | TRUE | 0 | 0 |
| 2025-01-17 | 55 | 0 | CALL | 0 | 0 | 34.78 | TRUE | 0 | 0 |
| 2025-01-17 | 60 | 3.8 | CALL | 0 | 4 | 34.97 | FALSE | 0 | 0 |
| 2025-01-17 | 65 | 2 | CALL | 0 | 0 | 33.54 | FALSE | 0 | 0 |
| 2025-01-17 | 70 | 2.05 | CALL | 0 | 3 | 43.71 | FALSE | 0 | 0 |
| 2025-01-17 | 75 | 1.85 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 80 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 85 | 1.15 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 90 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 95 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 100 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 30 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 35 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 45 | 0.75 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 50 | 0 | PUT | 0 | 0 | 51.32 | FALSE | 0 | 0 |
| 2025-01-17 | 55 | 4.7 | PUT | 0 | 18 | 41.31 | FALSE | 0 | 0 |
| 2025-01-17 | 60 | 0 | PUT | 0 | 0 | 31.11 | TRUE | 0 | 0 |
| 2025-01-17 | 65 | 6.9 | PUT | 0 | 30 | 31.59 | TRUE | 0 | 0 |
| 2025-01-17 | 70 | 11.8 | PUT | 0 | 35 | 33.52 | TRUE | 0 | 0 |
| 2025-01-17 | 75 | 15 | PUT | 0 | 20 | 33.36 | TRUE | 0 | 0 |
| 2025-01-17 | 80 | 15 | PUT | 0 | 0 | 36.78 | TRUE | 0 | 0 |
| 2025-01-17 | 85 | 0 | PUT | 0 | 0 | 44.66 | TRUE | 0 | 0 |
| 2025-01-17 | 90 | 0 | PUT | 0 | 0 | 82.54 | TRUE | 0 | 0 |
| 2025-01-17 | 95 | 0 | PUT | 0 | 0 | 88.89 | TRUE | 0 | 0 |
| 2025-01-17 | 100 | 0 | PUT | 0 | 0 | 57.6 | TRUE | 0 | 0 |
| 2025-04-17 | 30 | 0 | CALL | 0 | 0 | 56.81 | TRUE | 0 | 0 |
| 2025-04-17 | 35 | 0 | CALL | 0 | 0 | 49.45 | TRUE | 0 | 0 |
| 2025-04-17 | 40 | 0 | CALL | 0 | 0 | 40.97 | TRUE | 0 | 0 |
| 2025-04-17 | 45 | 0 | CALL | 0 | 0 | 42.62 | TRUE | 0 | 0 |
| 2025-04-17 | 50 | 0 | CALL | 0 | 0 | 36.16 | TRUE | 0 | 0 |
| 2025-04-17 | 55 | 8.29 | CALL | 0 | 1 | 34.14 | TRUE | 0 | 0 |
| 2025-04-17 | 60 | 5 | CALL | 0 | 1 | 37.3 | FALSE | 0 | 0 |
| 2025-04-17 | 65 | 3.4 | CALL | 0 | 2 | 30.36 | FALSE | 0 | 0 |
| 2025-04-17 | 70 | 2.5 | CALL | 0 | 6 | 38.15 | FALSE | 0 | 0 |
| 2025-04-17 | 75 | 0 | CALL | 0 | 0 | 38.11 | FALSE | 0 | 0 |
| 2025-04-17 | 80 | 0 | CALL | 0 | 0 | 44.21 | FALSE | 0 | 0 |
| 2025-04-17 | 85 | 0.9 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 30 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 35 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 45 | 0 | PUT | 0 | 0 | 52.92 | FALSE | 0 | 0 |
| 2025-04-17 | 50 | 0 | PUT | 0 | 0 | 40.48 | FALSE | 0 | 0 |
| 2025-04-17 | 55 | 4.5 | PUT | 0 | 5 | 32.78 | FALSE | 0 | 0 |
| 2025-04-17 | 60 | 6.2 | PUT | 0 | 1 | 32.61 | TRUE | 0 | 0 |
| 2025-04-17 | 65 | 0 | PUT | 0 | 0 | 30 | TRUE | 0 | 0 |
| 2025-04-17 | 70 | 0 | PUT | 0 | 0 | 30.11 | TRUE | 0 | 0 |
| 2025-04-17 | 75 | 15.6 | PUT | 0 | 20 | 27.47 | TRUE | 0 | 0 |
| 2025-04-17 | 80 | 0 | PUT | 0 | 0 | 31.84 | TRUE | 0 | 0 |
| 2025-04-17 | 85 | 0 | PUT | 0 | 0 | 35.15 | TRUE | 0 | 0 |
Latest ANIP Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:58 PM EST | 11182 | $24 |
| Jun 13, 2022 7:58 PM EST | 140 | $24 |
| Jun 13, 2022 7:59 PM EST | 100 | $24 |
| Jun 13, 2022 7:59 PM EST | 3 | $23.98 |
| Jun 13, 2022 7:59 PM EST | 10 | $24.005 |
ANI Pharmaceuticals, Inc (ANIP) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920072312/0001104659-20-072312-index.htm |
| 2018-09-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1023024/000000000018028121/0000000000-18-028121-index.htm |
| 2018-10-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1023024/000000000018032671/0000000000-18-032671-index.htm |
| 2018-11-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1023024/000000000018035326/0000000000-18-035326-index.htm |
| 2020-07-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1023024/000000000020006407/0000000000-20-006407-index.htm |
| 2019-01-24 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1023024/000021545719001016/0000215457-19-001016-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1023024/000083423720001478/0000834237-20-001478-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1023024/000102302420000008/0001023024-20-000008-index.htm |
| 2019-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465919057517/0001104659-19-057517-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1023024/000110465919060283/0001104659-19-060283-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465919060284/0001104659-19-060284-index.htm |
| 2019-11-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465919067257/0001104659-19-067257-index.htm |
| 2019-12-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465919068992/0001104659-19-068992-index.htm |
| 2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465919069229/0001104659-19-069229-index.htm |
| 2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920002449/0001104659-20-002449-index.htm |
| 2020-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920005962/0001104659-20-005962-index.htm |
| 2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920023089/0001104659-20-023089-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1023024/000110465920025744/0001104659-20-025744-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920025748/0001104659-20-025748-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920041406/0001104659-20-041406-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920041409/0001104659-20-041409-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920041411/0001104659-20-041411-index.htm |
| 2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920044727/0001104659-20-044727-index.htm |
| 2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920044728/0001104659-20-044728-index.htm |
| 2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920044729/0001104659-20-044729-index.htm |
| 2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920044731/0001104659-20-044731-index.htm |
| 2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046388/0001104659-20-046388-index.htm |
| 2020-04-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/0001104659-20-046392-index.htm |
| 2020-04-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046393/0001104659-20-046393-index.htm |
| 2020-04-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046394/0001104659-20-046394-index.htm |
| 2020-04-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/0001104659-20-046395-index.htm |
| 2020-04-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046396/0001104659-20-046396-index.htm |
| 2020-04-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/0001104659-20-046397-index.htm |
| 2020-04-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046398/0001104659-20-046398-index.htm |
| 2020-04-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1023024/000110465920049964/0001104659-20-049964-index.htm |
| 2020-04-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1023024/000110465920049978/0001104659-20-049978-index.htm |
| 2020-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920052874/0001104659-20-052874-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920053944/0001104659-20-053944-index.htm |
| 2020-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1023024/000110465920054478/0001104659-20-054478-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1023024/000110465920057791/0001104659-20-057791-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920057797/0001104659-20-057797-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/0001104659-20-060890-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920061654/0001104659-20-061654-index.htm |
| 2020-05-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1023024/000110465920064517/0001104659-20-064517-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920068029/0001104659-20-068029-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920072312/0001104659-20-072312-index.htm |
| 2020-07-09 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920082375/0001104659-20-082375-index.htm |
| 2020-07-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1023024/000110465920084013/0001104659-20-084013-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920089648/0001104659-20-089648-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920091099/0001104659-20-091099-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920091450/0001104659-20-091450-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000110465920121560/0001104659-20-121560-index.htm |
| 2018-05-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418030783/0001144204-18-030783-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418030785/0001144204-18-030785-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418030787/0001144204-18-030787-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418030788/0001144204-18-030788-index.htm |
| 2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/0001144204-18-033524-index.htm |
| 2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033527/0001144204-18-033527-index.htm |
| 2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033529/0001144204-18-033529-index.htm |
| 2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033530/0001144204-18-033530-index.htm |
| 2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/0001144204-18-033532-index.htm |
| 2018-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420418041246/0001144204-18-041246-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420418042242/0001144204-18-042242-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1023024/000114420418042444/0001144204-18-042444-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420418042460/0001144204-18-042460-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420418049518/0001144204-18-049518-index.htm |
| 2018-09-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1023024/000114420418049849/0001144204-18-049849-index.htm |
| 2018-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420418055994/0001144204-18-055994-index.htm |
| 2018-10-31 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1023024/000114420418056446/0001144204-18-056446-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420418057434/0001144204-18-057434-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1023024/000114420418057627/0001144204-18-057627-index.htm |
| 2018-12-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420418066411/0001144204-18-066411-index.htm |
| 2019-01-02 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419000179/0001144204-19-000179-index.htm |
| 2019-02-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419004471/0001144204-19-004471-index.htm |
| 2019-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419008991/0001144204-19-008991-index.htm |
| 2019-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419010386/0001144204-19-010386-index.htm |
| 2019-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1023024/000114420419010541/0001144204-19-010541-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm |
| 2019-03-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419014333/0001144204-19-014333-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017402/0001144204-19-017402-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017403/0001144204-19-017403-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/0001144204-19-017405-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017408/0001144204-19-017408-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017409/0001144204-19-017409-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017410/0001144204-19-017410-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/0001144204-19-017412-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017413/0001144204-19-017413-index.htm |
| 2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/0001144204-19-017416-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017759/0001144204-19-017759-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017765/0001144204-19-017765-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017770/0001144204-19-017770-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017773/0001144204-19-017773-index.htm |
| 2019-04-04 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1023024/000114420419018181/0001144204-19-018181-index.htm |
| 2019-04-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1023024/000114420419018185/0001144204-19-018185-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419018898/0001144204-19-018898-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419018899/0001144204-19-018899-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419018900/0001144204-19-018900-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419018901/0001144204-19-018901-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419020281/0001144204-19-020281-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419020282/0001144204-19-020282-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419020283/0001144204-19-020283-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419023116/0001144204-19-023116-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1023024/000114420419024656/0001144204-19-024656-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419024658/0001144204-19-024658-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419025603/0001144204-19-025603-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/0001144204-19-026614-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026615/0001144204-19-026615-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm |
| 2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026945/0001144204-19-026945-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/0001144204-19-027313-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419028634/0001144204-19-028634-index.htm |
| 2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419030641/0001144204-19-030641-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419036760/0001144204-19-036760-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1023024/000114420419038053/0001144204-19-038053-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1023024/000114420419038054/0001144204-19-038054-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm |
| 2019-08-23 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000114420419041520/0001144204-19-041520-index.htm |
| 2020-08-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002066/0001415889-20-002066-index.htm |
| 2020-08-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002067/0001415889-20-002067-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002068/0001415889-20-002068-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002069/0001415889-20-002069-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm |
| 2020-09-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002283/0001415889-20-002283-index.htm |
| 2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002285/0001415889-20-002285-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1023024/000155837020009520/0001558370-20-009520-index.htm |
| 2020-07-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1023024/999999999520001852/9999999995-20-001852-index.htm |
| 2019-02-22 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1023024/999999999719000563/9999999997-19-000563-index.htm |
| 2019-02-22 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1023024/999999999719000565/9999999997-19-000565-index.htm |
| 2019-03-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1023024/999999999719001398/9999999997-19-001398-index.htm |
| 2019-07-01 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1023024/999999999719005909/9999999997-19-005909-index.htm |
| 2020-04-02 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1023024/999999999720001310/9999999997-20-001310-index.htm |
| 2020-04-02 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1023024/999999999720001312/9999999997-20-001312-index.htm |
| 2020-04-14 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1023024/999999999720001568/9999999997-20-001568-index.htm |
| 2020-05-15 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1023024/999999999720002915/9999999997-20-002915-index.htm |
ANI Pharmaceuticals, Inc (ANIP) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ANI Pharmaceuticals, Inc (ANIP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 474%Institutional Ownership: 7946%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-03-04 | THOMAS HAUGHEY | Director | Buy | 3,000.00 | 45.05 | 135,150.00 | 11,291.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm |
| 2018-06-06 | Thomas A. Penn | Director | Buy | 1,200.00 | 12,310.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033527/0001144204-18-033527-index.htm | ||
| 2020-04-10 | DAVID NASH | Director | Buy | 7,119.00 | 12,355.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046396/0001104659-20-046396-index.htm | ||
| 2020-04-10 | Patrick D Walsh | Director | Buy | 9,255.00 | 13,046.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/0001104659-20-046395-index.htm | ||
| 2019-03-28 | Thomas A. Penn | Director | Buy | 1,991.00 | 14,301.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017402/0001144204-19-017402-index.htm | ||
| 2018-06-06 | Robert E. JR Brown | Director | Buy | 1,200.00 | 17,768.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/0001144204-18-033524-index.htm | ||
| 2018-06-06 | DAVID NASH | Director | Buy | 1,800.00 | 1,800.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033530/0001144204-18-033530-index.htm | ||
| 2018-06-06 | Patrick D Walsh | Director | Buy | 1,800.00 | 1,800.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/0001144204-18-033532-index.htm | ||
| 2018-06-06 | THOMAS HAUGHEY | Director | Buy | 1,800.00 | 1,800.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420418033529/0001144204-18-033529-index.htm | ||
| 2020-04-10 | THOMAS HAUGHEY | Director | Buy | 7,119.00 | 18,410.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046398/0001104659-20-046398-index.htm | ||
| 2020-05-11 | Patrick D Walsh | Interim President and CEO | Buy | 7,050.00 | 20,096.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/0001104659-20-060890-index.htm | ||
| 2019-05-15 | ARTHUR PRZYBYL | President and CEO | Sell | 14,633.00 | 69.25 | 1,013,335.25 | 202,589.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm |
| 2019-03-28 | Robert E. JR Brown | Director | Buy | 2,584.00 | 20,352.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/0001144204-19-017405-index.htm | ||
| 2019-03-18 | ARTHUR PRZYBYL | President and CEO | Sell | 24,802.00 | 63.53 | 1,575,671.06 | 205,076.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm |
| 2019-03-19 | ARTHUR PRZYBYL | President and CEO | Sell | 2,823.00 | 63.51 | 179,288.73 | 205,076.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm |
| 2019-05-16 | Robert E. JR Brown | Director | Buy | 1,042.00 | 6.36 | 6,627.12 | 21,394.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm |
| 2019-05-14 | ARTHUR PRZYBYL | President and CEO | Sell | 5,772.00 | 70.45 | 406,637.40 | 217,222.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm |
| 2019-08-20 | VENTURE PARTNERS II LP MERIDIAN | 10% Share Holder | Sell | 5,512.00 | 68.18 | 375,808.16 | 2,219,259.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm |
| 2019-08-19 | VENTURE PARTNERS II LP MERIDIAN | 10% Share Holder | Sell | 2,067.00 | 68.30 | 141,176.10 | 2,224,771.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm |
| 2019-08-16 | VENTURE PARTNERS II LP MERIDIAN | 10% Share Holder | Sell | 26,349.00 | 68.09 | 1,794,103.41 | 2,226,838.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm |
| 2019-05-13 | ARTHUR PRZYBYL | President and CEO | Sell | 9,595.00 | 71.10 | 682,204.50 | 222,994.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm |
| 2019-08-15 | VENTURE PARTNERS II LP MERIDIAN | 10% Share Holder | Sell | 9,315.00 | 69.34 | 645,902.10 | 2,253,187.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm |
| 2019-05-16 | Robert E. JR Brown | Director | Buy | 1,167.00 | 33.00 | 38,511.00 | 22,561.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm |
| 2019-08-14 | VENTURE PARTNERS II LP MERIDIAN | 10% Share Holder | Sell | 26,360.00 | 69.89 | 1,842,300.40 | 2,262,502.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm |
| 2019-08-13 | VENTURE PARTNERS II LP MERIDIAN | 10% Share Holder | Sell | 20,821.00 | 71.77 | 1,494,323.17 | 2,288,862.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm |
| 2020-08-10 | Patrick D Walsh | CHAIRMAN, INTERIM PRES. & CEO | Buy | 3,000.00 | 30.40 | 91,200.00 | 23,096.00 | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm |
| 2019-08-12 | VENTURE PARTNERS II LP MERIDIAN | 10% Share Holder | Sell | 21,016.00 | 71.45 | 1,501,593.20 | 2,309,683.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm |
| 2019-08-09 | VENTURE PARTNERS II LP MERIDIAN | 10% Share Holder | Sell | 19,860.00 | 71.70 | 1,423,962.00 | 2,330,699.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm |
| 2019-03-28 | ARTHUR PRZYBYL | President and CEO | Buy | 37,280.00 | 242,356.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017410/0001144204-19-017410-index.htm | ||
| 2019-03-28 | STEPHEN P. CAREY | Vice President and CFO | Buy | 12,451.00 | 26,569.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017409/0001144204-19-017409-index.htm | ||
| 2020-08-10 | Patrick D Walsh | CHAIRMAN, INTERIM PRES. & CEO | Buy | 4,000.00 | 30.98 | 123,920.00 | 27,096.00 | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm |
| 2020-09-08 | Nikhil Lalwani | PRESIDENT & CEO | Buy | 28,508.00 | 28,508.00 | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002285/0001415889-20-002285-index.htm | ||
| 2020-04-10 | Robert E. JR Brown | Director | Buy | 7,119.00 | 29,680.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/0001104659-20-046397-index.htm | ||
| 2020-08-10 | Patrick D Walsh | CHAIRMAN, INTERIM PRES. & CEO | Buy | 3,000.00 | 30.89 | 92,670.00 | 30,096.00 | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm |
| 2019-03-28 | DAVID NASH | Director | Buy | 1,991.00 | 3,791.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017413/0001144204-19-017413-index.htm | ||
| 2019-03-28 | Patrick D Walsh | Director | Buy | 1,991.00 | 3,791.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/0001144204-19-017416-index.htm | ||
| 2019-03-28 | THOMAS HAUGHEY | Director | Buy | 1,991.00 | 3,791.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017408/0001144204-19-017408-index.htm | ||
| 2018-09-11 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Buy | 28,688.00 | 6.60 | 189,340.80 | 47,842.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420418049518/0001144204-18-049518-index.htm |
| 2019-03-12 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Sell | 5,642.00 | 64.44 | 363,578.38 | 47,842.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm |
| 2019-03-12 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Sell | 1,503.00 | 64.50 | 96,943.50 | 47,842.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm |
| 2019-03-13 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Sell | 4,651.00 | 64.43 | 299,645.79 | 47,842.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm |
| 2019-03-12 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Buy | 1,503.00 | 33.00 | 49,599.00 | 49,345.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm |
| 2019-05-24 | DAVID NASH | Director | Buy | 1,445.00 | 68.76 | 99,358.20 | 5,236.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419028634/0001144204-19-028634-index.htm |
| 2019-03-13 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Buy | 4,651.00 | 33.00 | 153,483.00 | 52,493.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm |
| 2019-03-12 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Buy | 5,642.00 | 28.76 | 162,263.92 | 53,484.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm |
| 2019-05-13 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Sell | 2,409.00 | 71.13 | 171,352.17 | 55,927.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419025603/0001144204-19-025603-index.htm |
| 2019-03-28 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Buy | 12,451.00 | 60,293.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017403/0001144204-19-017403-index.htm | ||
| 2019-05-17 | James G. Marken | SVP Ops & Prod Dev | Sell | 8,907.00 | 70.67 | 629,457.69 | 61,230.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/0001144204-19-027313-index.htm |
| 2019-05-15 | THOMAS HAUGHEY | Director | Buy | 2,500.00 | 69.30 | 173,240.00 | 6,291.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026615/0001144204-19-026615-index.htm |
| 2020-04-10 | STEPHEN P. CAREY | Vice President and CFO | Buy | 39,767.00 | 63,145.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046394/0001104659-20-046394-index.htm | ||
| 2019-05-14 | James G. Marken | SVP Ops & Prod Dev | Sell | 4,917.00 | 70.31 | 345,714.27 | 70,137.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/0001144204-19-026614-index.htm |
| 2020-08-05 | Antonio R Pera | Director | Buy | 7,421.00 | 7,421.00 | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002069/0001415889-20-002069-index.htm | ||
| 2020-08-05 | Jeanne Thoma | Director | Buy | 7,421.00 | 7,421.00 | https://www.sec.gov/Archives/edgar/data/1023024/000141588920002068/0001415889-20-002068-index.htm | ||
| 2019-03-28 | James G. Marken | SVP Ops & Prod Dev | Buy | 6,848.00 | 75,928.00 | https://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/0001144204-19-017412-index.htm | ||
| 2020-03-03 | THOMAS HAUGHEY | Director | Buy | 2,000.00 | 45.18 | 90,360.00 | 8,291.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm |
| 2020-04-10 | James G. Marken | SVP Ops & Prod Dev | Buy | 24,548.00 | 85,297.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/0001104659-20-046392-index.htm | ||
| 2020-04-10 | Robert W Schrepfer | SVP - New Bus Dev & Spec Sales | Buy | 39,767.00 | 93,043.00 | https://www.sec.gov/Archives/edgar/data/1023024/000110465920046393/0001104659-20-046393-index.htm |